Copyright
©The Author(s) 2023.
World J Hepatol. Mar 27, 2023; 15(3): 419-430
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.419
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.419
Figure 1 Clinical decision support tool workflow.
Fib-4: Fibrosis-4; NAFLD: Non-alcoholic fatty liver disease.
Figure 2 Cohort flow chart.
KPLAMC: Kaiser Permanente Los Angeles Medical Center; NAFLD: Non-alcoholic fatty liver disease; CDST: Clinical decision support tool.
Figure 3 Clinical management in first year following FibroScan.
A: Laboratory tests; B: Imaging studies and specialty referral. CDST: Clinical decision support tool; CT: Computerized tomography; MRI: Magnetic resonance imaging.
- Citation: Stein L, Mittal R, Song H, Chung J, Sahota A. To scan or not to scan: Use of transient elastography in an integrated health system. World J Hepatol 2023; 15(3): 419-430
- URL: https://www.wjgnet.com/1948-5182/full/v15/i3/419.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i3.419